Projects funded by the NCN

Targeting MMP-9 in Cancer Treatment: Computational Design and Experimental Validation of Potent, Safe Antitumor Agents

Call: SONATA BIS 15 , Panel: ST5

Principal investigator: dr Anna Żądło-Dobrowolska

Instytut Chemii Organicznej Polska Akademia Nauk

Application of voltammetry and gravimetry for simultaneous detection of matrix metalloproteinases -1, -2 and -9 in human...

Call: OPUS 18 , Panel: ST4

Principal investigator: prof. Anna Maria Nowicka

Uniwersytet Warszawski, Wydział Chemii

Therapeutic potential of biased 5-HT7 receptor ligands in the treatment of depression

Call: OPUS 17 , Panel: NZ7

Principal investigator: prof. Paweł Maria Zajdel

Uniwersytet Jagielloński, Collegium Medicum

Influence of administration of cathinones, on the example of mephedrone, in adolescence and on fenotype of adult rats - ...

Call: OPUS 13 , Panel: NZ7

Principal investigator: prof. Jolanta Helena Kotlińska

Uniwersytet Medyczny w Lublinie, Wydział Farmaceutyczny

Identification of molecular mechanisms responsible for the MMP-9-1562C/T- dependent differential regulation of Matrix Me...

Call: PRELUDIUM 13 , Panel: NZ3

Principal investigator: Sylwia Weronika Pabian-Jewuła

CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

The role of Fragile X Mental Retardation Protein in the local translation of Matrix Metalloproteinase 9 in neurons.

Call: HARMONIA 4 , Panel: NZ4

Principal investigator: dr Magdalena Dziembowska

Instytut Biologii Doświadczalnej im. M. Nenckiego PAN

mRNA stabilization-dependent regulation of MMP-9 (Matrix Metalloproteinase-9) mRNA expression after the neuronal activat...

Call: OPUS 3 , Panel: NZ3

Principal investigator: dr hab. Marcin Bartłomiej Rylski

CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO

Epigenetic regulation of pro-epileptic protease Matrix Metalloproteinase-9 expression in the hippocampus during epilepto...

Call: OPUS 1 , Panel: NZ2

Principal investigator: dr hab. Marcin Bartłomiej Rylski

CENTRUM MEDYCZNE KSZTAŁCENIA PODYPLOMOWEGO